Who owns CYTEIR THERAPEUTICS INC?
- Ticker: CYT
- CUSIP Number: 23284p103
Tip: Access positions for across all investors
Analyze quarterly positions in Cyteir Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cyteir Therapeutics stock
Who bought or sold CYTEIR THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BML Capital Management | 3.3M | $9.9M | 0% | Dec 2023 |
|
Newtyn Management | 3.0M | $9.2M | 21% | Dec 2023 |
|
OUP Management | 2.5M | $7.0M | 0% | Sep 2023 |
|
Frigate Ventures | 1.3M | $3.8M | 15% | Sep 2023 |
|
FMR | 827k | $2.3M | 0% | Sep 2023 |
|
Vanguard Group | 687k | $2.1M | 7% | Dec 2023 |
|
Novo A/S | 676k | $1.9M | -82% | Sep 2023 |
|
Millennium Management | 452k | $1.4M | 100% | Dec 2023 |
|
Gabelli Funds | 443k | $1.3M | 100% | Sep 2023 |
|
Walleye Trading Advisors | 427k | $1.3M | 21% | Dec 2023 |
|
Gabelli Securities | 416k | $1.2M | 100% | Sep 2023 |
|
Laurion Capital Management | 316k | $961k | -12% | Dec 2023 |
|
Brooklyn Capital Management | 200k | $608k | 0% | Dec 2023 |
|
Geode Capital Management | 164k | $465k | 37% | Sep 2023 |
|
Aldebaran Capital | 144k | $408k | 0% | Sep 2023 |
|
Alta Fundamental Advisers | 117k | $333k | 100% | Sep 2023 |
|
Rbf Capital | 117k | $333k | 0% | Sep 2023 |
|
Renaissance Technologies | 105k | $297k | -25% | Sep 2023 |
|
Bank of America Corporation | 89k | $272k | 11% | Dec 2023 |
|
BlackRock | 86k | $243k | -3% | Sep 2023 |
|
Squarepoint Ops | 67k | $204k | 32% | Dec 2023 |
|
Bank Of Montreal | 66k | $204k | 100% | Dec 2023 |
|
Pale Fire Capital SE | 58k | $164k | 0% | Sep 2023 |
|
CSS | 55k | $168k | -3% | Dec 2023 |
|
State Street Corporation | 46k | $131k | 93% | Sep 2023 |
|
Jane Street | 42k | $127k | 100% | Dec 2023 |
|
Northern Trust | 34k | $97k | 80% | Sep 2023 |
|
Wittenberg Investment Management | 29k | $81k | 100% | Sep 2023 |
|
Caas Capital Management | 26k | $80k | 0% | Dec 2023 |
|
Boston Family Office | 24k | $74k | 0% | Dec 2023 |
|
Hrt Financial | 16k | $48k | 100% | Dec 2023 |
|
Charles Schwab Investment Management | 16k | $49k | 0% | Dec 2023 |
|
Landscape Capital Management | 13k | $40k | 100% | Dec 2023 |
|
Tower Research Capital | 6.9k | $20k | 305% | Sep 2023 |
|
Royal Bank of Canada | 5.4k | $16k | 100% | Dec 2023 |
|
Lindbrook Capital | 2.0k | $6.1k | 0% | Dec 2023 |
|
Morgan Stanley | 1.0k | $2.8k | -83% | Sep 2023 |
|
Wolverine Asset Management | 570.00 | $1.7k | 0% | Dec 2023 |
|
Wells Fargo & Company | 147.00 | $446.997600 | 6% | Dec 2023 |
|
Jpmorgan Chase & Co | 124.00 | $376.997200 | -75% | Dec 2023 |
|
Qube Research & Technologies | 4.00 | $11.000000 | 100% | Sep 2023 |
|
Who sold out of Cyteir Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
VR Advisory Services | Sep 2023 | 1.1M | $3.0M |
Acuitas Investments | Sep 2023 | 329k | $935k |
Evercore Wealth Management | Jun 2023 | 147k | $381k |
Cantor Fitzgerald, L. P. | Sep 2023 | 133k | $376k |
Virtu Financial | Sep 2023 | 80k | $228k |
Marquette Asset Management | Sep 2023 | 68k | $193k |
Vazirani Asset Management | Sep 2023 | 16k | $45k |